Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagn

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 88, 424 86, 424 858, 424450, 530324, 530328, 530329, 530350, 514 12, 514 13, 514 14, 514 15, 514 17, A61K 3912, A61K 3702, C07K 706, C07K 710

Patent

active

048615889

ABSTRACT:
A hepatitis B vaccine containing a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the envelope of hepatitis B virus. The vaccine being free of an amino acid sequence corresponding to the naturally occurring envelope proteins of hepatitis B virus and a physiologically acceptable diluent. The peptide being free or linked to a carrier. The carrier being a conventional carrier or a novel carrier including a lipid vesicle stabilized by cross-linking and having covalently bonded active sites on the outer surface thereon. Such novel carrier being useful not only to link the novel peptide containing an amino acid chain with amino acids within the pre-S gene coded region of the surface antigen of hepatitis B virus, but can also be used to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen and parasitic proteins of man and animals. The peptides of the invention can be utilized in diagnostics for the detection of antigens and antibodies.

REFERENCES:
patent: 4415491 (1983-11-01), Vyas
patent: 4428941 (1984-01-01), Galibert et al.
patent: 4599230 (1986-06-01), Milich et al.
patent: 4683136 (1987-04-01), Milich et al.
Chemical Abstracts, Machida et al., vol. 101, p. 34691 (1984).
Chemical Abstracts, Neurath et al., vol. 101, p. 5397 (1984).
B. B. Mandel, "Virus Neutralization", Immunochemistry of Viruses, The Basis for Serodiagnosis and Vaccines, (1985).
Elsevier Science Publishers B. V., pp. 53-70 and W. S. Robinson, "Hepatitis B Virus"/Viral Hepatitis: Laboratory and Clincal Science, edited by F. Deinhardt and J. Deinhardt, Marcel Dekker, Inc., pp. 57-116 (1983).
Chemical Abstracts, vol. 100, No. 19, May 7, 1984, p. 139, ref. No. 151965c; Columbus OH, US & JP-A-58 194897 (Takeda Che. Ind. Ltd) 12-11-1983.
Journal of Virology, vol. 46, No. 2, May 1983, pp. 626-628, Am. Soc. for Microbiology, US W. Stibbe et al.: "Structural Relationship between minor and major proteins of Hepatitis B surface antigen."
Gastroenterology, vol. 85, No. 2, 1983, pp. 268-274; Am. Gastroenterological Ass., US A. Machida et al.: "A Hepatitis B surface Antigen Polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins."
Proc. Nat. Acad Sci. USA, vol. 78, No. 6, June 1981, pp. 3824-3828; US, T. P. Hopp et al.: "Prediction of protein antigenic determinants from amino acid sequences".
Experientia, vol. 38, No. 5, May 1982, pp. 629-630; Basel, CH P. K. Das et al.: "Liposomes as immunological carriers for the preparation of antimannosyl antibodies." p. 629, column 1, lines 12-13, column 2, lines 1-2.
Gastroenterology, vol. 86, 1984, pp. 910-918; Am. Gastroenterological Ass., US A. Machida et al.: "A polypeptide containing 55 amino acid residues coded by the pre-S region of Hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins."
Science, vol. 224, Apr. 27, 1984, pp. 392-395, A. R. Neurath et al.: "Location and chemical synthesis of a pre-S gene coded immunodominant epitope of Hepatitis B virus".
Nature, vol. 317, No. 6037, Oct. 1985, pp. 489-495 London, GB; P. Tiollais et al: "The hepatitus B virus".
Journal of Virology, vol. 52, No. 2, Nov. 1984, pp. 396-402, American Society for Microbiology, US; K. H. Heermann et al: "Large surface proteins of Hepatitis B virus containing the Pre-S sequence".
Virology, vol. 130, 1983, pp. 76-90, Academic Press, Inc. US; M. A. Feitelson et al: "The nature of polypeptides larger in size than the major surface antigen components of like viruses in ground squirrels, Hepatitis B and like viruses in ground squirrels, woodchucks, and ducks".
W. Szmuness, Prog. Med. Virol. 24, 40 (1978).
R. P. Beasley, L.-Y. Hwang, C.-C. Ling, C.-S. Chien, Lancet Nov., 21, 1129 (1981).
S. Krugman, in Viral Hepatitis: Laboratory and Clinical Science, F. Deinhardt, J. Deinhardt, Eds., Marcel Dekker, Inc., New York-Basel, 1983, pp. 257-263.
B. S. Blumberg, Science, 197, 17, (1977).
P. Tiollais, P. Charnay, G. N. Vyas, Science, 213, 406, (1981).
G. Le Bouvier, A. Williams, Am. J. Med. Sci., 270, 165 (1975).
W. Szmuness, C. E. Stevens, E. H. Harley, E. A. Zang, H. J. Alter, P. E. Taylor, A. DeVera, G. T. S. Chen, A. Kellner, et al., N. Engl. J. Med., 307, 1481, (1982).
J. W.-K. Shih, J. L. Gerin, J. Immunol., 115, 634, (1975).
J. W.-K. Shih, P. L. Tan, J. L. Gerin, J. Immunol., 120, 520, (1978).
S. Mishiro, M. Imai, K. Takahashi, A. Machida, T. Gotanda, Y. Miyakawa, J. Mayumi, J. Immunol., 124, 1589, (1980).
G. R. Dressman, R. Chairez, M. Suarez., F. B. Hollinger, R. J. Courtney, J. L. Melnick, J. Virol, 16, 508, (1975).
N. Williams, Nature, 306, 427, (1983).
W. Stibbe, W. H. Gerlich, Virology, 123, 436, (1982).
M. A. Feitelson, P. L. Marion, W. S. Robinson, Virology, 130, 76, (1983).
W. Stibbe, W. H. Gerlich, J. Virol., 46, 626, (1983).
A. Machida, S. Kishimoto, H. Ohnuma, H. Miyamoto, K. Bab, K. Oda, T. Nakamura, Y. Miyakawa, M. Mayumi, Gastroenterology, 85, 268, (1983).
Nima, H. L., Houghten, R. A., Walker, L. E., Reisfeld, R. A., Wilson, I. A., Hogle, J. M. and Lerner, R. A., "Generation of Protein-Reactive Antibodies by Short Peptides is an Event of High Frequency: Implications for the Structural Basis of Immune Recognition", Proceedings of the National Academy of Sciences USA, 80, 4949-4953, (1983).
Pfaff, E., Mussgay, M., Bohm, H. O., Schulz, G. E. and Schaller, H., "Antibodies Against A Preselected Peptide Recognize and Neutralize Foot and Mouth Disease Virus", The EMBO Journal, 7, 869-874, (1982).
Neurath, A. R., Kent, S. B. H. and Strick, N., "Specificity of Antibodies Elicited by a Synthetic Peptide Having a Sequence in Common with a Fragment of a Virus Protein, The Hepatitis B Surface Antigen," Proceedings of the National Academy of Sciences USA 79, 7871-7875, (1982).
Ionescu-Matiu, I., Kennedy, R. C., Sparrow, J. T., Culwell, A. R. Sanchez, Y., Melnick, J. L. and Dressman, G. R., "Epitopes Associated with a Synthetic Hepatitis B Surface Antigen Peptide", The Journal of Immunology, 130, 1947-1952, (1983).
Kennedy, R. C., Dreesman, G. R., Sparrow, J. T., Culwell, A. R., Sanchez, Y., Ionescu-Matiu, I., Hollinger, F. B. and Melnick, J. L. (1983).
"Inhibition of a Common Human Anti-Hepatitis B Surface Antigen Idiotype by a Cyclic Synthetic Peptide," Journal of Virology, 46, 653-655, (1983).
Dressman, G. R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J. T., Six, H. R., Peterson, D. L., Hollinger, F. B. and Meinick, J. L., "Antibody to Hepatitis B. Peptides can be Immunogenic".
Dressman, G. R., Sanchez, Y., ionescu-Matiu, I., Sparrow, J. T., Six H. R., Peterson, D. L., Hollinger, F. B. and Melnick, J. L., "Antibody to Hepatitis B Surface Antigen After a Single Inoculation of Uncoupled Synthetic HBsAg Peptides" Nature, 295, 158-160, (1982).
Schmitz, H. E., Atassi, H., and Atassi, M. Z., "Production of Monoclonal Antibodies to Surface Regions that are Non-Immunogenic In A Protein Using Free Synthetic Peptide as Immunogens: Demonstration with Sperm-Whale Myoglobin", Immunological Communications, 12, 161-175, (1983).
Sanchez, Y., Ionescu-Matiu, I., Sparrow, J. T., Melnick, J. L., Dressman, G. R., "Immunogenicity of Conjugates and Micelles of Synthetic Hepatitis B Surface Antigen Peptides", Intervirology, 18, 209-213, (1982).
K. Lonberg-Holm and L. Philipson, eds. Receptors and Recognition, Series B. vol. 8, Virus Receptors: Part 2-Animal Viruses. (London: Chapman and Hall), pp. 85-211, (1981).
B. N. Fields and M. I. Greene, "Genetic and Molecular Mechanisms of Viral Pathogenesis: Implications for Prevention and Treatment", Nature, 300, 19-23, (1982).
A. H. Sharpe and B. N. Fields, "Pathogenesis of Viral Infections: Basic Concepts Derived from the Reovirus Model", New Engl. J. Med., 312, 486-497, (1985).
D. A. Eppstein, Y. V. Marsh, A. B. Schreiber, S. R. Newman, G. J. Todaro and J. J. Nestor, "Epidermal Growth Factor Receptor Occupancy Inhibits Vaccinia Virus Infection", Nature, 318, 663-665, (1985).
B. Mandel, Virus Neutralization, In Immunochemistry of Viruses: The Basis for Serodiagnosis and Vaccines, M. H. V. Van Regenmort

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagn does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagn will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2236983

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.